Keyphrases
Tumorigenesis
100%
C-Myc
100%
Receptor Expression
100%
Retinoic Acid Receptor
100%
Retinoic Acid Receptor Agonist
100%
AM580
100%
Tumor Growth
12%
Mammary Epithelium
8%
Breast Cancer
8%
Tumor Inhibition
8%
Transgenic Mouse Model
8%
Selective Agonist
8%
Cell Death
4%
Clinical Trials
4%
Cell Survival
4%
Cell Differentiation
4%
Cell Proliferation
4%
Overexpression
4%
Overexpressing
4%
Breast Cancer Cell Lines
4%
Expression Level
4%
Embryonic Development
4%
Response to Treatment
4%
Mouse Model
4%
Cell Tumor
4%
Functional Consequences
4%
Breast
4%
Mammary Tumor
4%
Mammary Tumor Cells
4%
In Vivo Effects
4%
In Vitro Experiment
4%
Lung Metastasis
4%
E-cadherin
4%
Immunohistochemical Analysis
4%
Retinoic Acid Signaling
4%
Oncogene Expression
4%
Responsive Genes
4%
Tumor Latency
4%
Receptor Targets
4%
Target Gene Expression
4%
Mammary Cancer
4%
Mammary Gland
4%
Benzoic Acid
4%
Stem Cell Compartment
4%
Epithelial Cancer Cells
4%
Mammary Gland Tumor
4%
Adult Tissues
4%
Naphthyl
4%
Mammary Tumorigenesis
4%
MYC Oncogene
4%
Human Mammary Cell Lines
4%
OncoMouse
4%
CYP26A1
4%
Cellular Retinol-binding Protein
4%
Immunology and Microbiology
Agonist
100%
Oncogene C Myc
100%
Mouse Mammary Tumor Virus
100%
Isotype
50%
Mouse Model
33%
Mammary Gland
33%
Cell Proliferation
16%
Stem Cell
16%
Tumor Cell
16%
Breast Cancer Cell Line
16%
Cell Differentiation
16%
Normal Human
16%
Gene Expression
16%
Prevalence
16%
Cell Death
16%
Growth Inhibition
16%
Cell Line
16%
Transgenic Mouse
16%
Protein Binding
16%
Cadherin
16%
Embryo Development
16%
Transgenic Organism
16%
Epithelial Cancer Cell Line
16%
Oncomouse
16%
Naphthalene
16%
In Vitro
16%
Medicine and Dentistry
Carcinogenesis
100%
Receptor Expression
100%
Oncogene C Myc
100%
Retinoic Acid Receptor
100%
Mouse Mammary Tumor Virus
100%
4 [(5,6,7,8 Tetrahydro 5,5,8,8 Tetramethyl 2 Naphthyl)carboxamido]benzoic Acid
100%
Breast Cancer
12%
Breast Tumor
12%
Tumor Progression
8%
Cancer Inhibition
8%
Mammary Epithelium
8%
Cell Death
4%
Prevalence
4%
Clinical Trial
4%
Neoplasm
4%
Cell Differentiation
4%
Cell Proliferation
4%
In Vitro
4%
Cell Line
4%
Gene Expression
4%
Transgenic Mouse
4%
Tretinoin
4%
Lung Metastasis
4%
Embryo Development
4%
Cell Compartment
4%
Breast Cancer Cell Line
4%
Uvomorulin
4%
Stem Cell
4%
Epithelial Cancer Cell Line
4%
Protein P27
4%
Cellular Retinol Binding Protein 1
4%
Tumor Growth
4%
Biochemistry, Genetics and Molecular Biology
Carcinogenesis
100%
Oncogene C Myc
100%
Retinoic Acid Receptor
100%
Receptor Agonists
100%
Myc
100%
Mouse Mammary Tumor Virus
100%
Tumor Progression
16%
Agonist
12%
Mouse Model
8%
Cancer Cell
4%
Cell Death
4%
Cell Proliferation
4%
Clinical Trial
4%
Stem Cell
4%
Prevalence
4%
Transgenic Mouse
4%
Cellular Differentiation
4%
Embryogenesis
4%
Gene Expression
4%
Normal Human
4%
Growth Inhibition
4%
Tretinoin
4%
Retinoic Acid
4%
Synapsin I
4%
Retinol Binding Protein
4%
Transgenic Organism
4%
Oncomouse
4%
Cadherin
4%
Pharmacology, Toxicology and Pharmaceutical Science
Carcinogenesis
100%
Receptor Agonist
100%
Mouse Mammary Tumor Virus
100%
Retinoic Acid Receptor
100%
4 [(5,6,7,8 Tetrahydro 5,5,8,8 Tetramethyl 2 Naphthyl)carboxamido]benzoic Acid
100%
Breast Cancer
16%
Breast Tumor
12%
Tumor Growth
8%
Mouse Model
8%
Cancer Inhibition
8%
Prevalence
4%
Neoplasm
4%
Clinical Trial
4%
Normal Human
4%
Retinoic Acid
4%
Transgenic Mouse
4%
Lung Metastasis
4%
Uvomorulin
4%
Protein P27
4%
Transgenic Organism
4%
Cellular Retinol Binding Protein 1
4%
Oncomouse
4%